Loading company…
Nanjing Nuoling develops medical devices for nitric oxide therapy and monitoring.
Nanjing Nuoling develops portable nitric oxide therapy devices and exhaled nitric oxide detectors for conditions including pulmonary hypertension, diabetic foot and COPD. Founded in 2018 and based in Nanjing, China, it closed a Series C round in April 2025 to support production capacity, commercialization and overseas expansion of its portable inhalation therapy device.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in